Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_assertion type Assertion NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_head.
- NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_assertion wasGeneratedBy ECO_0000203 NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_provenance.
- NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_assertion wasDerivedFrom lhgdn-20090331 NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_provenance.
- NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_assertion SIO_000772 15342390 NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_provenance.
- NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_assertion evidence source_evidence_literature NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_provenance.
- NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_assertion description "[Results show that breast cancer development is characterized by either nuclear loss or cytoplasmic translocation of CITED4, with consequent loss of hypoxia-inducible factor-1alpha transcriptional antagonist activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP107396.RAiJMMucDCVPZb56I6JA3V3ACMWYD35wqn-TxgL5YvSDg130_provenance.